KeyNeurotek Pharmaceuticals
About:
KeyNeurotek is focused on developing small molecule drugs for the treatment of neuronal and autoimmune diseases.
Website: http://www.keyneurotek.de
Top Investors: KfW, Deutsche Venture Capital, IBG Beteiligungsgesellschaft Sachsen-Anhalt
Description:
KeyNeurotek is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases.
Total Funding Amount:
8.2M EUR
Headquarters Location:
Magdeburg, Sachsen-Anhalt, Germany
Founded Date:
2000-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2009-04-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai